Wiesner, R H <br/><br/>
Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Jul 2006 
 - 1609-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6135 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2006.01382.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--immunology<br/>Hepacivirus--drug effects<br/>Hepatitis B--drug therapy<br/>Hepatitis B virus--drug effects<br/>Hepatitis C--drug therapy<br/>Humans<br/>Liver Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Risk Factors<br/>Time Factors